Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for tb patients not infected with HIV

Clinical and Vaccine Immunology

Volumn 20, Issue 9, 2013, Pages 1479-1482

  Savolainen, Laura ^a   Kantele, Anu ^a,b,c   Sandboge, Bettina ^a   Sirén, Marita ^a   Valleala, Heikki ^b   Tuompo, Riitta ^b   Pusa, Liana ^d   Erkinjuntti Pekkanen, Riitta ^e,f   Knuuttila, Aija ^b   Ku, Cheng Lung ^g   Chi, Chih Yu ^h   Vasankari, Tuula ⁱ   Tuuminen, Tamara ^a,j  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Länsi Uusimaa Hospital   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g CHANG GUNG UNIVERSITY   (Taiwan)

^h CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ Finnish Lung Health Association   (Finland)

^j Mikkeli District Laboratory   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIPOARABINOMANNAN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FALSE POSITIVE RESULT; HUMAN; LATENT TUBERCULOSIS; LIPID ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; TUBERCULOSIS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; ANTIGENS, BACTERIAL; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84884690961     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00375-13     Document Type: Article

References (23)

1. Alere Inc. 2013. BinaxNOW Legionella test manual. Alere Inc., Waltham, MA.
2. Alere Inc. 2013. BinaxNOW S. pneumoniae test manual. Alere Inc., Waltham, MA.
3. Tam FC, Ling TK, Wong KT, Leung DT, Chan RC, Lim PL. 2008. The TUBEX test detects not only typhoid-specific antibodies but also soluble antigens and whole bacteria. J. Med. Microbiol. 57:316-323.
4. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. 2011. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur. Respir. J. 38:1398-1405.
5. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. 2010. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr. Opin. Pulm. Med. 16:262-270.
6. Lawn SD. 2012. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect. Dis. 12:103. doi:10.1186/1471-2334-12-103.
7. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. 2009. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a high HIV prevalence setting. J. Acquir. Immune Defic. Syndr. 52:145-151.
8. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, Ling D, Brunet L, van Zyl Smit R, Peter J, Green C, Badri M, Sechi L, Sharma S, Hoelscher M, Dawson R, Whitelaw A, Blackburn J, Pai M, Zumla A. 2010. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV infected patients using urine and sputum samples. PLoS One 5:e9848. doi:10.1371/journal.pone.0009848.
9. Conesa-Botella A, Loembe MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R, for the Group TB IRIS. 2011. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J. Acquir. Immune Defic. Syndr. 58:463-468.
10. Gounder CR, Kufa T, Wada NI, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, Grant A, Dorman S, Chaisson RE, Churchyard GJ. 2011. Diagnostic accuracy of a urine lipoarabinomannan enzymelinked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis. J. Acquir. Immune Defic. Syndr. 58:219-223.
11. Wood R, Racow K, Bekker LG, Middelkoop K, Vogt M, Kreiswirth BN, Lawn SD. 2012. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. BMC Infect. Dis. 12:47. doi:10.1186/1471-2334-12-47.
12. Talbot E, Munseri P, Teixeira P, Matee M, Bakari M, Lahey T, von Reyn F. 2012. Test characteristics of urinary lipoarabinomannan and predictors of mortality among hospitalized HIV-infected tuberculosis suspects in Tanzania. PLoS One 7:e32876. doi:10.1371/journal.pone.0032876.
13. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, Koulchin V, Hoelscher M. 2005. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 99:893-900.
14. Daley P, Michael JS, Hmar P, Latha A, Chordia P, Mathai D, John KR, Pai M. 2009. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int. J. Tuberc. Lung Dis. 13:989-995.
15. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, Wood R. 2009. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23:1875-1880.
16. Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, Mangwanya D, Mungofa S, Butterworth AE, Mason PR, Corbett EL. 2009. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int. J. Tuberc. Lung Dis. 13:1253-1259.
17. Reither K, Saathoff E, Jung J, Minja LT, Kroidl I, Saad E, Huggett JF, Ntinginya EN, Maganga L, Maboko L, Hoelscher M. 2009. Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect. Dis. 9:141. doi:10.1186/1471-2334-9-141.
18. Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. 2011. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol. Rev. 35:1126-1157.
19. Sopena N, Sabria M, Pedro-Botet ML, Reynaga E, Garcia-Nunez M, Dominguez J, Matas L. 2002. Factors related to persistence of Legionella urinary antigen excretion in patients with Legionnaires' disease. Eur. J. Clin. Microbiol. Infect. Dis. 21:845-848.
20. Dominguez JA, Manterola JM, Blavia R, Sopena N, Belda FJ, Padilla E, Gimenez M, Sabria M, Morera J, Ausina V. 1996. Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J. Clin. Microbiol. 34:2334-2336.
21. Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B. 2001. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand. J. Infect. Dis. 33:279-284.
22. Hamasur B, Bruchfeld J, Haile M, Pawlowski A, Bjorvatn B, Kallenius G, Svenson SB. 2001. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J. Microbiol. Methods 45:41-52.
23. Kanaujia GV, Lam PK, Perry S, Brusasca PN, Catanzaro A, Gennaro ML. 2005. Integration of microscopy and serodiagnostic tests to screen for active tuberculosis. Int. J. Tuberc. Lung Dis. 9:1120-1126.